Monday - November 3, 2025
New Targeted Therapy Shows Promise for Patients With Advanced Bladder Cancer
October 22, 2025
PHILADELPHIA, Pennsylvania, Oct. 22 [Category: Medical] -- The American Association for Cancer Research posted the following news release:

* * *

New Targeted Therapy Shows Promise for Patients With Advanced Bladder Cancer

*

BOSTON - FX-909, a first-in-class investigational oral small molecule inhibitor of peroxisome proliferator-activated receptor gamma (PPARG), showed early signs of clinical benefit in patients with advanced urothelial carcino . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products